We measured C5a concentrations in plasma from 19 unvaccinated COVID-19 patients and found a positive correlation with lymphocyte C3b deposition (R = 0.539, P = 0.0045) (Figure 4A), further supporting the in vivo systemic activation of complement. The gene discussed is C3; the disease is COVID-19.